Drug Loading and Distribution of ADCs After Reduction or IdeS Digestion and Reduction - Archive ouverte HAL Access content directly
Book Sections Year : 2020

Drug Loading and Distribution of ADCs After Reduction or IdeS Digestion and Reduction

Abstract

High-resolution native mass spectrometry (MS) provides accurate mass measurements (within 30 ppm) of intact ADCs and can also yield drug load distribution (DLD) and average drug to antibody ratio (DAR) in parallel with hydrophobic interaction chromatography (HIC). Native MS is furthermore unique in its ability to simultaneously detect covalent and noncovalent species in a mixture and for HIC peak identity assessment offline or online. As an orthogonal method described in this chapter, LC-MS following ADC reduction or IdeS (Fabricator) digestion and reduction can also be used to measure the DLD of light chain and Fd fragments for hinge native cysteine residues such as brentuximab vedotin. Both methods allow also the measurement of average DAR for both monomeric and multimeric species. In addition, the Fc fragments can be analyzed in the same run, providing a complete glycoprofile and the demonstration or absence of additional conjugation of this subdomain involved in FcRn and Fc-gammaR binding.
Not file

Dates and versions

hal-02341651 , version 1 (31-10-2019)

Identifiers

Cite

Elsa Wagner-Rousset, Olivier Colas, Yannis-Nicolas Francois, Sabine Heinisch, Davy Guillarme, et al.. Drug Loading and Distribution of ADCs After Reduction or IdeS Digestion and Reduction. Antibody-drug conjugates, pp.187-195, 2020, ⟨10.1007/978-1-4939-9929-3_12⟩. ⟨hal-02341651⟩
78 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More